Literature DB >> 10904794

Betahistine reduces the resting firing rate of vestibular receptors in the frog.

P Valli1.   

Abstract

Although betahistine is widely used in the treatment of vertigo, it remains unclear whether it directly affects the vestibular system at the peripheral level. The effects of betahistine were therefore assessed in an isolated preparation of frog semicircular canal. Betahistine was administered either in the endolymphatic or the perilymphatic fluid and the ampullar receptor potential and mass nerve discharge were recorded at rest and during mechanical stimulation. Endolymphatic administration was without effect. In contrast, perilymphatic administration resulted in a marked reduction in ampullar receptor resting discharge, although the mechanically evoked responses were only slightly affected. As vertigo is generally caused by sudden and uncontrolled changes in the resting discharge of vestibular receptors, the ability of betahistine to reduce the resting firing rate of vestibular receptors is thought to contribute to its anti-vertigo actions.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10904794     DOI: 10.1080/000164800750044416

Source DB:  PubMed          Journal:  Acta Otolaryngol Suppl        ISSN: 0365-5237


  3 in total

1.  Benign paroxysmal positional vertigo: a study of two manoeuvres with and without betahistine.

Authors:  M Cavaliere; G Mottola; M Iemma
Journal:  Acta Otorhinolaryngol Ital       Date:  2005-04       Impact factor: 2.124

2.  Meta-analysis of clinical studies with betahistine in Ménière's disease and vestibular vertigo.

Authors:  Jozef J P Nauta
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-06-19       Impact factor: 2.503

3.  Good Clinical Approach: Delphi Consensus for the Use of Betahistine in Menière's Disease.

Authors:  Augusto Pietro Casani; Elena Navari; Giorgio Guidetti; Michel Lacour
Journal:  Int J Otolaryngol       Date:  2018-10-25
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.